Bicycle Therapeutics
BCYC | NASDAQ
$3.73
+$0.10 (+2.75%)
Sep 22, 2026, 12:38 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 72.59M | 35.28M | 26.98M | 14.46M | 11.7M | 10.39M |
Cost of Revenue | n/a | 172.97M | 156.5M | n/a | n/a | 33.15M |
Gross Profit | 72.59M | -137.69M | -129.52M | 14.46M | 11.7M | -22.76M |
Operating Income | -247.72M | -209.87M | -189.95M | -116.65M | -65.62M | -51.96M |
Interest Income | 28.46M | 34.28M | 14M | 5.76M | 120K | 683K |
Pretax Income | -218.81M | -173.8M | -179.21M | -114.24M | -68.48M | -51.73M |
Net Income | -218.96M | -169.03M | -180.66M | -112.72M | -66.82M | -51.01M |
Selling & General & Admin | 80.02M | 71.46M | 59.83M | 49.51M | 32.44M | 29.2M |
Research & Development | 240.28M | 172.97M | 156.5M | 81.61M | 44.88M | 33.15M |
Other Expenses | n/a | -172.25M | -155.9M | n/a | n/a | -33.15M |
Operating Expenses | 320.3M | 72.18M | 60.43M | 131.12M | 77.32M | 29.2M |
Interest Expense | 206K | 1.73M | 3.26M | 3.34M | 2.98M | 457K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 320.3M | 245.15M | 216.92M | 131.12M | 77.32M | 62.35M |
Income Tax Expense | 152K | -4.77M | 1.46M | -1.52M | -1.66M | -724K |
Shares Outstanding (Basic) | 69.28M | 58.21M | 35.59M | 29.66M | 25.06M | 19.15M |
Shares Outstanding (Diluted) | 69.28M | 58.21M | 35.59M | 29.66M | 25.06M | 19.15M |
EPS (Basic) | -3.16 | -2.91 | -5.08 | -3.80 | -2.67 | -2.66 |
EPS (Diluted) | -3.16 | -2.90 | -5.08 | -3.80 | -2.67 | -2.66 |
EBITDA | -212.18M | -164.89M | -169.4M | -107.21M | -64.09M | -50.68M |
EBIT | -218.6M | -172.07M | -175.94M | -110.9M | -65.5M | -51.96M |
Depreciation & Amortization | 6.42M | 7.18M | 6.55M | 3.69M | 1.41M | 1.28M |
Add to Watchlist
Select watchlists to add or remove BCYC